TwentyEight-Seven's Series A Round

TwentyEight-Seven raised a round of funding on September 06, 2018.

TwentyEight-Seven is a Cambridge, MA-based drug development firm developing small-molecule drugs that target RNA regulatory proteins, and modulate the function of specific ncRNAs that have causative r…

Articles about TwentyEight-Seven's Series A Round: